Roslin Covid-19 research
Work by scientists at the Roslin Institute investigating the novel coronavirus.
This page lists news stories about our Covid-19 and coronavirus findings and projects as well as related scientific publications.
Protein linked to severe Covid-19
Patients with severe Covid-19 have been found to show increased levels of a key protein in their blood, in a development that could help identify those most at risk.
Levels of the protein were nearly 10 times higher in those who died from Covid-19 than in healthy individuals, the study has found.
Increased protein levels could help to identify patients at risk in early stages of disease and provide a target for new treatments, researchers say.
Sewage signals early warning of Covid-19 outbreaks
Monitoring programmes put into operation to quickly identify localised coronavirus outbreaks.
Fragments of coronavirus have been detected in wastewater samples across Scotland and in England and Wales, in projects designed to enable early warning of local outbreaks of Covid-19 infection.
The approach, developed with support from Roslin scientists, tests for genetic material from the coronavirus in wastewater.
Most people infected with the coronavirus are believed to shed it in their faeces even if they have no symptoms, so wastewater analysis can help identify local outbreaks ahead of rising hospital admissions.
Genetic insight holds promise of Covid-19 vaccine
Detailed knowledge of the genetic code of the novel coronavirus could support efforts to develop a vaccine.
Insights into the genetic makeup of the virus behind Covid-19 could help develop vaccines and possible treatments for infection.
Key characteristics of the genetic code of the coronavirus – known as SARS-CoV-2 – could point to ways in which it could be modified for use in vaccines, or could highlight suitable targets for drug treatments.
The findings, from a study by Roslin scientists, also shed light on the origins of the virus.
Experts warn of second Covid-19 peak in winter
A combination of environmental factors plus pressure on healthcare provision could lead to a further spike in cases.
A second wave of coronavirus infections, more serious than the first, could impact the UK this winter, according to research involving Roslin scientists.
A further peak of the outbreak, combined with existing disruption to the health service, a patient backlog, and the possibility of a flu epidemic, poses a serious risk to health in the UK, according a new report from the Academy of Medical Sciences.
Low-cost drug curbs deaths in serious Covid-19 cases
The widely available drug dexamethasone reduces death rates in hospitalised patients with severe respiratory complications from Covid-19, research has shown. In the study, led by scientists from the University of Oxford, 2104 patients received the drug. It reduced deaths by one-third in ventilated patients and by one-fifth in other patients receiving oxygen. It had no benefit among patients who did not need respiratory support.
Dr Kenneth Baillie, Senior Clinical Research Fellow in Anaesthesia and Critical Care at the University of Edinburgh’s Centre for Inflammation Research and the Roslin Institute, has been involved in setting up trials and is part of the steering committee. The researchers are now working to publish the full details.
Face coverings can cut risk of coronavirus spread
Scientists testing the effectiveness of seven types of face covering, including medical-grade and home-made masks, found that they could all potentially help limit the spread of the novel coronavirus. However, some of the masks enabled strong jets of air to escape from the back and sides.
Obesity impacts on Covid-19 recovery prospect
Being obese reduces the chance of survival in severe cases of Covid-19, a study has found. Reduced lung function and inflamed tissue under the skin and around internal organs could be linked to the increased risk. Being male is also linked with more serious Covid-19 hospital admissions.
Covid-19 tracker helps visualise cases in Scotland
A dashboard pulling together data from several sources on the Covid-19 outbreak in Scotland provides a picture of how the situation is developing. Data on the global trajectory of the pandemic is also available.
Experts are upbeat about quest for Covid treatment
Leading scientists from Universities of Edinburgh, including the Roslin Institute, and Dundee have joined a €77.7 million initiative to find a treatment for Covid-19 and say they are optimistic progress can be made.
Health care requirements
A study will predict the effects of Covid-19 on the demand for primary health care and hospital resources in Edinburgh and south-east Scotland by looking at available data.
Home DNA test data sought for Covid-19 study
Researchers are asking people who have used DNA testing services – such as Ancestry DNA, FTDNA and 23andMe –to join a study that aims to identify key genes involved in the body’s response to the infection.
Genetics of Covid-19 patients is focus of study
Researchers are to study the genetic blueprints of severely ill Covid-19 patients to find out why the disease affects some more seriously than others and suggest potential treatments.
Campus volunteers support Covid-19 research
More than 70 members of staff from the Roslin Institute and the Royal (Dick) School of Veterinary Studies have volunteered to support research tackling Covid-19 involving all UK coronavirus patients in intensive care.
Data method seeks weak spots in coronavirus genome
Regions of the coronavirus genome that could be targeted to disrupt the virus can be predicted by a new machine learning method. The findings could help to develop vaccines and drug treatments against the virus.
Virus transmission in Scotland
The rise and fall in Covid-19 cases in Scotland will be tracked as part of a £62,000 project led by Roslin scientist Dr Samantha Lycett. The team will compare the virus’ genetic makeup in different areas of the country and combine this with models of the incidence, distribution and spread of the virus in the population.
Scottish funding supports Roslin Covid-19 work
Three awards from the Scottish Government will support scientists working to track the spread of the coronavirus by looking at its genetic makeup in different areas of Scotland, investigating the effects of severe Covid-19 in the body, and 3D printing personalised protective equipment for healthcare workers.
£5m Covid-19 study seeks to understand virus impact
A scientist from the Roslin Institute is leading a £4.9 million project seeking to aid understanding of Covid-19 and its impact on the human body.
Antiviral therapies and vaccine strategies
Roslin researchers are studying molecular details of the virus’s interaction with host cells, with an aim to identifying antiviral therapies and potential ways to improve vaccine strategies.
Researchers are working to trace when and how the current coronavirus first transmitted from an animal to a person. By knowing this, they can explore what factors made it possible for the virus to spread. Teams at Roslin are also investigating similarities between the latest virus and other related viruses.
Roslin researchers are part of the Scottish Covid-19 Response Consortium and are adapting their models, data analysis and visualisation tools to determine patterns of Covid-19 transmission in Scotland and wider UK. In related work, scientists are developing computer models to help health bodies better understand regional differences in risks and to plan for changes in control. Researchers are also developing methods to track the novel coronavirus via municipal wastewater.
- Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe Covid-19
- Face coverings, aerosol dispersion and mitigation of virus transmission risk
- Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol